Synthesis and evaluation of symmetric (1,4-diazepane-1,4-diyl)bis(phenylmethanone) derivatives as amyloid-beta aggregation inhibitors
Med Chem Res (2025). DOI: 10.1007/s00044-025-03512-3
Relationship between efficacy and preferential targeting of soluble Aβ aggregates
Alzheimer’s Association (2025), (Vol 11, Issue 4). DOI: 10.1002/trc2.70184
Protocol for in vitro phagocytosis assay for primary mouse microglia and human embryonic stem cell-derived microglia
STAR Protocols (2025), (Vol 6, Issue 4). DOI: 10.1016/j.xpro.2025.104219.
The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia
Nat Neurosci (2025). DOI: 10.1038/s41593-025-02125-8
Targeting of amyloid peptide fibers, a biomarker of Alzheimer’s disease, by designing specifically functionalized Iron Oxide Nanoparticles
HAL. (2025), 8 (43), pp.20822-20834. DOI:10.1021/acsanm.5c03459
Role of P-glycoprotein in attenuation of retinal amyloid-β peptide (1–40) clearance across the rat inner blood-retinal barrier induced by lipopolysaccharide
Science Direct (2025), 262. DOI: 10.1016/j.exer.2025.110759.
Detection of extracellular amyloid beta aggregates by an Aducanumab-based synNotch receptor: an in vitro proof-of-concept study
J Transl Med 23, 1255 (2025). DOI: 10.1186/s12967-025-07324-2
Inhibitory Effect of Insulin-Degrading Enzyme-Selective Inhibitor, Ii1, on the Elimination of Amyloid-β(1-40) from Rat Brain
Biol. Pharm. Bull. 48, 1700–1707 (2025). DOI: 10.1248/bpb.b25-00424
Cell-type-specific dysregulation of mitochondrial calcium signaling in Alzheimer’s disease
Cell Commun Signal 23, 472 (2025). DOI: 10.1186/s12964-025-02460-0
The involvement of microglia and the CXCL16-CXCR6 axis in the recruitment of CD8+ T cells to an amyloidogenic mouse brain
Sci Rep 15, 38221 (2025). DOI: 10.1038/s41598-025-22137-5